Blog
Busting the myth that pen-and-paper is better than electronic outcome assessments
Clinical outcome assessments administered with pen-and-paper tasks have long been the assessment method of choice for measuring treatment effects on patients. However, with the advent of electronic alternatives - how do these two assessment methods compare?
Cambridge Cognition signs new eCOA contracts
Cambridge Cognition today announced it has won a significant new phase IV clinical trial contract for use of its electronic clinical outcomes assessment (eCOA) platform, CANTAB Connect.
web-based testing,
wearables,
voice recognition,
voice,
virtual clinical trials,
technology,
swm,
subjective measures,
stigma,
social cognition,
smartphones,
schizophrenia research,
schizophrenia,
safety,
research funding,
research,
remote testing,
regulations,
recruitment,
rare disease,
psychosis,
prodromal,
pro-cognitive,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient recruitment,
parkinson's disease,
pal,
paired associates learning,
occupational health,
objective measures,
normative data,
neuroscience,
near-patient testing,
multiple sclerosis,
ms,
modelling,
mental wellbeing,
mental health at work,
mental health,
mdd,
mci,
major depression,
machine learning,
longitudinal,
hot cognition,
high-frequency testing,
high frequency,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
ecoa,
ebt,
early career researchers,
early alzheimer's disease,
drug development,
digital tools,
digital health,
depression,
dementia,
cognitive wellbeing,
cognitive testing,
cognitive science,
cognitive safety,
cognitive research,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab,
brain health,
biomarkers,
awards,
automatic speech recognition,
autism,
asr,
asd,
alzheimer's disease,
absenteeism,
aaic2020,
